Covid vaccine: Merck has not yet been counted out of the race
IO blockbusters from Merck, BMS, and more related to poor COVID-19 results: study
In the month ending April 7, 423 cancer patients at Memorial Sloan Kettering Cancer Center were diagnosed with COVID-19, 20% of whom developed severe respiratory symptoms. That in itself was not surprising, given that cancer patients are immunocompromised and therefore face an increased risk of fighting the virus. But a …
Read More »